论文部分内容阅读
中国医药集团信息化以敏捷供应链,积极应对新医改形势下医药行业竞争格局的转变。 2009年4月6日新医改正式出台,医药产业将迎来新一轮的格局调整和洗牌。对医药企业来说,基本药物领域将是今后竞争的重点,而基本药物的物流则是极为关键的一环。如何在新的规则变化中获取市场先机?医药企业所要采取的信息策略需要随之做出怎样的调整和改变?针对这个问题,在10月26日《CIO INSIGHT/信息方略》主办的2009中美CIO峰会——医疗行业分论坛上,中国医药集团总公司信息化专家小组组长雷万云博士,诠释
China National Pharmaceutical Group to agile supply chain information, and actively cope with the new medical reform situation in the pharmaceutical industry changes in the competitive landscape. April 6, 2009 formally introduced the new medical reform, the pharmaceutical industry will usher in a new round of restructuring and reshuffle. For pharmaceutical companies, the field of essential drugs will be the focus of competition in the future, while the logistics of essential drugs is a crucial part. How to get market opportunities in the new rules changes? What kind of adjustments and changes should be made to the information strategy to be adopted by pharmaceutical companies? In response to this question, in 2009, hosted by CIO INSIGHT / Information Strategy on October 26 US CIO Summit - Medical Industry Sub-forum, Dr. Lei Wanyun, Group Leader of Information Technology Group, China National Pharmaceutical Group Corporation, Interpretation